Physician profile
Donna Desantis
NPI 1134157449
$1,202.19
in general payments reported to CMS, 2019-2025
9 companies · $393 in 2025
The $393 reported for 2025 was more than what 78% of General Practice (Registered Nurse) providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $58.14 · 2023: $323 · 2024: $179 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $333.03 | 2021-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.26 | 2024-2025 | |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Lilly USA, LLC | $123.48 | 2025 | Zepbound |
| Astrazeneca Pharmaceuticals Lp | $117.87 | 2025 | Fasenra |
| Inspire Medical Systems, INC. | $90.25 | 2023 | Inspire |
| Boston Scientific Corporation | $77.27 | 2021 | |
| Abbott Laboratories | $67.66 | 2023 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company Ltd. | $24.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Desantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.